Developments of Phase 3 Trial: BOSTON Bortezomib in combination with Selinexor for treating Myeloma - 101931

Spotlight
Video

Developments of Phase 3 Trial: BOSTON Bortezomib in combination with Selinexor for treating Myeloma

ASHReport has 256 videos Subscribe Here

Loading........
Description: Michael Kauffman, MD and CEO from Karyopharm Therapeutics Inc discusses developments of Phase 3 trial: BOSTON - Bortezomib in combination with Selinexor for treating myeloma at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/22/18
Added : 30 days ago
Category : Multiple Myeloma



Recommended

Nothing found.

More From ASHReport

Nothing found.